Pirtobrutinib and Venetoclax Combined With Minimal Residual Disease Detection for Previously Untreated Chronic Lymphocytic Leukemia, MIRACLE Study

Conditions:   Chronic Lymphocytic Leukemia;   Small Lymphocytic Lymphoma Interventions:   Procedure: Biospecimen Collection;   Procedure: Bone Marrow Aspiration;   Procedure: Bone Marrow Biopsy;   Procedure: Computed Tomography;   Procedure: Magnetic Resonance Imaging;   Drug: Pirtobrutinib;   Procedure: Positron Emission Tomography;   Drug: Venetoclax Sponsors:   Mayo Clinic;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials